Dr. Arlen is the  President, CEO and Chief Medical Officer of Precision Biologics. Prior to joining Precision Biologics, Inc., he served as President, CEO, and Chief Medical Officer at Neogenix Oncology, Inc. Dr. Arlen spent 11 years at the National Cancer Institute, USA, most recently as the...

Roy Baynes is Senior Vice President Global Clinical Development and Chief Medical  Officer at Merck Research Laboratories in Rahway, New Jersey. He was previously  Senior Vice President of Oncology, Inflammation and Respiratory Therapeutics at Gilead Sciences and prior to that was Vice...

Jo Brewer has been with Adaptimmune since 2009,  leading teams covering research into basic T cell biology, hematopoietic stem cells, vector enhancements and translational science. She has 16 years of research experience in immunology and the biotech industry, specialising in TCRs and adoptive T...

Dr  Norman Begg is head of Scientific Affairs and Public Health at GlaxoSmithKline Vaccines, in Wavre, Belgium. He has held a number of positions since joining GSK in 2000, including clinical development (paediatric vaccines) and Chief Medical Officer. He is a public health physician who worked for ...

Tanja de Gruijl heads the Immunotherapy and Immune monitoring Lab at the Cancer Center of the VU University medical center (VUmc) in Amsterdam, where she has been appointed Professor of Translational Tumour Immunology. Her research ranges from preclinical topics to immune monitoring of Phase I-III...

Dr. Carrier is the Vice President of Vaccine Technology and Engineering at Takeda Vaccines where his responsibilities include technical operations and process engineering for commercial manufacturing of Takeda's global vaccine programs.  Prior to Takeda, Dr. Carrier held management roles at...

Ali Harandi is a chief scientist and lab head at University of Gothenburg with long standing interest in vaccine research, in particular characterization of immune responses to vaccines. Ali Harandi has been serving as principal scientist in several European and international collaborative projects ...

Dr. Adrian B. McDermott has more than 20 years experience as an experimental virologist and immunologist, in the fields of vaccines and HIV, including, the elucidation and characterization of T and B cell responses associated with control of replication or protection from HIV or SIV...

Dr. Krishna Ella is the Chairman & Managing Director of Bharat Biotech International Limited. After early education in Agricultural Sciences, Dr. Ella studied at the University of Hawaii and the University of Wisconsin-Madison. Following a brief stint as a research faculty at the Medical...

Over 20 years of experience working in biotech, coordinating efforts focused on the discovery and development of novel biologic based therapies. Began biotechnology career at Human Genome Sciences, where directed genomic-based target discovery programs and the preclinical development of various...

Dafne Müller received her doctoral degree from the University of Stuttgart in Germany. At the present she holds a group leader position at the department of Biomedical Engineering at the Institute of Cell Biology and Immunology of the University of Stuttgart. Working in the field of recombinant...

Martin Friede is the coordinator of the Initiative for Vaccine research (IVR) at the World Health Organization in Geneva, Switzerland.  In this position Dr Friede provides leadership to WHO’s activities on vaccine research including development of vaccine research policies, strategies and...

Laura has 15 years of experience in the pharmaceutical industry, having joined the field after being awarded research fellowships at Cornell University (Ithaca, NY, USA) and the University of Cambridge (Cambridge, UK). She obtained her doctorate from Harvard University (Boston, MA, USA). With a...

Maja A. Sommerfelt is Chief Scientific Officer at Bionor Pharma AS. She has a BSc. in microbiology from the University of London and a PhD in virology from the Institute of Cancer Research at the University of London, UK. She has carried out post-doctoral research at the University of Alabama at...

Dr.Suresh Jadhav, M.Pharm., Ph.D. is the Executive Director of Serum Institute of India Pvt. Ltd., one of the largest vaccine manufacturers from the developing countries, supplying vaccines to more than 170 countries through U.N. Agencies at most affordable prices.  His 45 years technical expertise ...

Dr. Maltais is an immunologist by training and holds a Ph.D. in Immunobiology from the Karolinska Institute, where she focused on vaccine adjuvants and vaccine delivery. She has previously worked as Vice President, Corporate Development at Cyto Pulse Sciences Inc., a U.S. company focusing on...

Dr Marie-Paule Kieny was appointed Assistant Director-General at the World Health Organization (WHO) in October 2010 and is now leading the Health Systems and Innovation cluster. Prior to this, Dr Kieny directed the WHO Initiative for Vaccine Research since its inception in 2001. Major successes...

Professor K. Vijay Raghavan is the Secretary, Department of Biotechnology, Government of India since January 28, 2013. Before that, he was the Director of the National Centre for Biological Sciences (NCBS) of the Tata Institute of Fundamental Research (TIFR) and the interim head of The Institute of ...

Dr. David Shao is CFO of Yisheng Biopharma Co., Ltd.  a multinational vaccine company with business focus in China, USA and Sinbgapore.   Dr. Shao has over 15 years of experience in US biopharmaceutical and capital.  He was the former CFO of Aoxing Pharmaceutical (NYSE Listed), a Senior Healthcare...

Dr. Vidadi M. Yusibov, the Executive Director of Fraunhofer USA Center for Molecular Biotechnology, is responsible for the oversight of all plant-based vaccine and therapeutics development programs. Dr. Yusibov has been involved in different aspects of plant molecular biology, including molecular...